vector season (@diangelo_mike) header
vector season (@diangelo_mike) profile picture

prod is my homelab now

Joined March 2022
Replying to @grok
@grok o que é agentic-coding?
1
treatment timing also depended on genotype and viral load, not just disease progression
In 2006, a leather craftsman from Tuscany died of hepatitis C in California. His son was 23 and studying physics at Princeton. The son's name was Dario Amodei. Four years after his father Riccardo died, a new treatment turned hepatitis C from a coin-flip disease into one that was 95% curable. The cure came. It just came too late. That changed everything about what Dario Amodei would do with his life. He dropped theoretical physics. Moved to Stanford. Started studying proteins in and around tumors to understand how cancer spreads. He spent years trying to decode biology the hard way, one experiment at a time. Then in 2014, he was diagnosed with testicular cancer. Went through chemotherapy. Recovered fully. He later said that if he had been living in 1950, he probably would have died. Two diseases. Two brushes with the speed of science. One took his father because the cure arrived four years too slow. The other spared him because medicine had moved just fast enough. By 2021, he had left OpenAI and started Anthropic with his sister Daniela. By 2026, the company was valued at $965 billion. Run-rate revenue hit $14 billion. Eight of the Fortune 10 became customers. But Amodei was not building a chatbot company. He was building the thing he wished had existed when his father was dying. Then came the part almost nobody is talking about. When Amodei says AI will cure cancer, Alzheimer's, heart disease, and mental illness in less than ten years, he is not making a keynote prediction. He is describing the reason Anthropic exists. He wrote a 15,000-word essay in October 2024 calling it "the compressed 21st century." His claim was specific. Powerful AI could compress 50 to 100 years of biological progress into 5 to 10 years. Not by replacing scientists. By doing the parts of research that take decades of trial and error and doing them in weeks. Doctors pushed back. Gary Marcus called it impossible. Oncologists pointed out that the average cancer drug still only extends survival by a few months. But Amodei was not speaking from a stage. He was speaking from a hospital bed he had already been in once. From a funeral he had already attended once. From a timeline he had already lost to once. In aviation, the difference between a safe landing and a crash is sometimes four seconds of decision-making. In medicine, the difference between a life saved and a life lost is sometimes four years of research. Dario Amodei watched that four-year gap kill his father. Now he runs a company worth nearly a trillion dollars, and every product it ships is pointed at closing that gap. This is not optimism. This is a debt.
这个recipe用了什么工具?.
19